Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rankning i aktier #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Aktiekurs
$101.91
Marknadsvärde
$177.09B
Förändring (1 dag)
-1.97%
Förändring (1 år)
-19.78%
Land
US
Handel Abbott Laboratories (ABT)

Kategori

Antal utestående aktier för Abbott Laboratories (ABT)
Antal utestående aktier per December 2025: 1.75B
Enligt de senaste finansiella rapporterna och aktiekursen för Abbott Laboratories är det aktuella antalet utestående aktier 1.75B. I slutet av December 2024 hade företaget 1.73B utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Abbott Laboratories (ABT) från 2000 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 1.75B 0.00%
2025 1.75B 0.88%
2024 1.73B -0.14%
2023 1.73B -1.08%
2022 1.75B -1.24%
2021 1.78B 0.11%
2020 1.77B 0.28%
2019 1.77B 0.71%
2018 1.76B 0.69%
2017 1.74B 18.38%
2016 1.47B 0.01%
2015 1.47B -2.35%
2014 1.51B -2.59%
2013 1.55B -1.81%
2012 1.58B 0.40%
2011 1.57B 1.51%
2010 1.55B 0.03%
2009 1.55B 0.19%
2008 1.54B 0.03%
2007 1.54B 0.87%
2006 1.53B -1.46%
2005 1.55B -0.52%
2004 1.56B -0.14%
2003 1.56B 0.12%
2002 1.56B 0.68%
2001 1.55B 0.15%
2000 1.55B 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
382.50M -78.11%
US
1.28B -26.58%
IE
1.28B -26.61%
IE
1.48B -15.13%
US
2.23B 27.85%
DE